Tumor cells circulating in blood are markers for the early detection and prognosis of cancer.
However, detection of these cells is challenging because of their scarcity. In the journal Angewandte Chemie, scientists have now introduced an ultrasensitive method for the direct detection of circulating tumor cells in blood samples. It is based on the amplified, time-resolved fluorescence measurement of luminescent lanthanide ions released from nanoparticles that bind specifically to tumor cells.
Conventional techniques for the detection of circulating tumor cells require complicated enrichment before detection because a sample of 10 million blood cells only contains about one tumor cell. In contrast, the new method developed by a team working with Xiaorong Song, Xueyuan Chen, and Zhuo Chen, at Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fujian Agriculture and Forestry University, and Fujian Cancer Hospital (Fuzhou, Fujian, China), works with no enrichment step and directly detects circulating tumor cells in blood samples. The technique is based on a so-called “dissolution-enhanced time-resolved photoluminescence” and uses fluorescing nanoparticles made of lanthanide europium complex.
First the researchers produced antibodies against the epithelial cell adhesion molecule (EpCAM, which is a glycoprotein that is present in very high numbers on the surfaces of many tumor cells and acts as a diagnostic marker for cancer). These antibodies were applied as a coating in the wells of microplates, causing tumor cells contained in the blood sample to remain stuck deep in the wells as other blood components were removed.
The scientists coated the europium-containing nanoparticles with the same antibodies. This caused large numbers of the nanoparticles, added in solution, to specifically bind to the tumor cells. A subsequently added “developer” dissolved the nanoparticles, releasing myriad europium ions. These were immediately bound and tightly locked up by other components of the developer solution. This resulted in a manifold amplification of the fluorescence.
Another essential advantage of this method is that europium ions are very long-lived fluorophores that continue to fluoresce for several microseconds after excitation with a flash of light. Because the measurements are time-resolved, it is possible to start the measurement with a delay. Background signals caused by the autofluorescence of cell components only continue for a few nanoseconds and fade before the measurement begins. This increases the sensitivity of the measurements, making it possible for the researchers to detect a single tumor cell per microplate well.
Tests with blood samples from cancer patients registered as few as 10 cells per milliliter of blood. Fourteen out of fifteen cancer patients were correctly identified by this new method. The number of tumor cells in the samples correlated strongly with the stage of cancer in each patient.
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Oral cancer pain may help predict metastasison October 7, 2020 at 4:44 pm
Oral cancer is more likely to spread in patients experiencing high levels of pain, according to a team of researchers at New York University College of Dentistry that found genetic and cellular clues ...
- Hard-hit Peru's costly bet on cheap COVID-19 antibody testson October 7, 2020 at 4:11 pm
In the early days of the coronavirus pandemic, the harried health officials of Peru faced a quandary. They knew molecular tests for COVID-19 were the best option to detect the virus – yet they didn’t ...
- Michigan PFAS activist has cancer, says she’s not surprisedon October 7, 2020 at 2:33 pm
A woman who was honored by the federal government for her environmental activism in western Michigan has been diagnosed with cancer. Sandy Wynn-Stelt told WOOD-TV ...
- Oral cancer pain predicts likelihood of cancer spreadingon October 7, 2020 at 2:26 pm
Oral cancer is more likely to spread in patients experiencing high levels of pain, according to a team of researchers at New York University (NYU) College of Dentistry that found genetic and cellular ...
- Belmont woman fighting PFAS diagnosed with canceron October 7, 2020 at 1:00 pm
The Belmont woman who became the face of the nationwide fight against PFAS has been diagnosed with a cancer tied to the chemical.
- A COVID-19-Cancer Interplayon October 7, 2020 at 12:29 pm
S impact on cancer treatment and research ...
- Cancer tests and coronavirus swabs sitting in warehouse unable to be shipped to NHS labson October 6, 2020 at 10:54 am
Roche Diagnostics confirmed to Sky News that problems at its distribution warehouse in Newhaven in East Sussex means GPs and hospitals will have to ration blood tests and screening for diseases ...
- COVID-19 antibody tests available at OneBlood blood drive in Veniceon October 6, 2020 at 8:53 am
OneBlood is conducting a blood drive from 10 a.m. to 4 p.m., Wednesday and Thursday at Venice City Hall, 401 W. Venice Ave., Venice. All successful donors will receive a free COVID-19 antibody test.
- What coverage does Medicare provide for bladder cancer?on October 6, 2020 at 4:54 am
Medicare covers treatment and services relating to bladder cancer. Some out-of-pocket costs may apply. Read on for more information.
- Large Study shows 230 Times Higher One Year Cancer Risk If Tumor Cell Clusters are Detected in Blood of Normal Individuals - Datar Cancer Geneticson September 28, 2020 at 6:28 am
A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has ...
via Bing News